Insights

Following the announcement of Made Scientific’s partnership with NurExone Biologic for GMP manufactu...

Most CDMO evaluations are designed to answer one question: can this partner manufacture the product?...

Our Chairman and CEO, Syed T. Husain, recently sat down with PharmaBoardroom to talk about where cel...

One qualified iPSC bank can support large numbers of doses. That is the platform advantage, and it a...

By the time an iPSC-derived product reaches release testing, most of what determines its quality was...

For short-life ATMPs, sterility is assured throughout the entire manufacturing process, not by a sin...

Rethinking CAR-T Manufacturing: A Single-Step Path to Lower COGS and Higher Yield Autologous CAR-T t...

Designing an operational model for autologous T cell manufacturing is only the starting point. Execu...

From process design to patient delivery, success depends on how the manufacturing system operates un...

From activation through gene modification and expansion, small development decisions often determine...